The rising demand for ketamine, mainly for emotional conditions, presents considerable challenges regarding the dispensing and private transport within the United States. Stringent national guidelines govern this process, necessitating compliance from vendors. Moreover, maintaining patient anonymity through thorough packaging and authorized transpo